Precision gene editing could prevent vision loss from Stargardt disease
Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...
AZoLifeSciences on MSN20h
New Gene Editing Therapy Shows Promise for Treating Stargardt Disease
Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most ...
Breakthrough Gene Editing Technique Offers Hope for Stargardt Disease Patients
Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most common form of ...
GEN1d
Base Editing Addresses Inherited Macular Degeneration in Primate, Human Tissue Models
The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.
The Globe and Mail19d
Stargardt Disease Therapeutics Market Size in the 7MM was ~USD 27 million in 2023, which is expected to increase by 2034, estimated DelveInsight
DelveInsight’s “Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted ...
BreakingNews.ie3d
Sisters to highlight rare eye condition at BT science exhibition
Caitlin and Caoimhe Mynes stole the hearts of viewers when they had the craic with Ryan Tubridy making lava lamps and glitter ...
Alkeus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today ...
Geode Capital Management LLC Has $6.23 Million Stake in Ocugen, Inc. (NASDAQ:OCGN)
Geode Capital Management LLC grew its stake in shares of Ocugen, Inc. (NASDAQ:OCGN – Free Report) by 6.3% in the third quarter, according to its most recent disclosure with the SEC. The fund owned ...